Voglibose
Voglibose (pronounced: voh-gli-boh-se) is an anti-diabetic medication used to improve postprandial hyperglycemia in people with type 2 diabetes. It is an alpha-glucosidase inhibitor, which means it works by slowing down the action of enzymes that break down carbohydrates in the gut, thereby reducing the rise in blood sugar levels after meals.
Etymology
The term "Voglibose" is derived from the chemical name N-(1-((1S,2S,3R,4S)-4-hydroxy-2,5,5-trimethylcyclohexyl)amino)-1-deoxy-D-fructosyl)-L-valine, which describes its chemical structure. The name is not associated with any particular language or historical context.
Usage
Voglibose is typically prescribed as part of a comprehensive treatment plan for type 2 diabetes, which may also include diet, exercise, weight control, regular blood sugar testing, and special medical care. It is usually taken three times daily, immediately before each meal.
Side Effects
Like all medications, Voglibose can cause side effects. Common side effects include stomach pain, bloating, diarrhea, and skin rash. If these side effects persist or worsen, patients are advised to contact their healthcare provider immediately.
Related Terms
See Also
External links
- Medical encyclopedia article on Voglibose
- Wikipedia's article - Voglibose
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski